Research Tools; Steroids; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
您的位置：
